Attached files

file filename
EX-99.1 - EX-99.1 - TENET HEALTHCARE CORPa13-20690_1ex99d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 


 

Date of Report:  September 13, 2013

(Date of earliest event reported)

 


 

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

 

Nevada

 

1-7293

 

95-2557091

(State of Incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification Number)

 

1445 Ross Avenue, Suite 1400

Dallas, Texas  75202

(Address of principal executive offices, including zip code)

 

(469) 893-2200

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 7.01              Regulation FD Disclosure

 

On September 13, 2013, Tenet Healthcare Corporation (the “Company” or “Tenet”) issued a press release announcing the pricing of its previously announced private placement offering of $2.8 billion in aggregate principal amount of senior unsecured notes and $1.8 billion in aggregate principal amount of senior secured notes. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01    Financial Statements and Exhibits.

 

(a)           The following exhibits are filed as a part of this Report.

 

Exhibit No.

 

Description

99.1

 

Press release announcing pricing of private placement offering.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

TENET HEALTHCARE CORPORATION

 

 

 

 

Date: September 13, 2013

 

 

By:

/s/ Paul Castanon

 

 

Name: Paul Castanon

 

 

Title:   Vice President, Deputy General Counsel and Corporate Secretary

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1

 

Press release announcing pricing of private placement offering.

 

4